Clinical forms of Trypanosoma cruzi infected individuals in the chronic phase of Chagas disease in Puebla, Mexico María del Carmen Sánchez-Guillén; Aurelio López-Colombo; Guillermo Ordóñez-Toquero; Isidoro Gomez-Albino; Judith Ramos-Jimenez; Enrique Torres-Rasgado; Hilda Salgado-Rosas; Mónica Romero-Díaz; Patricia Pulido-Pérez; Ricardo Pérez-Fuentes PAGE: 733-740 | DOI: S0074-02762006000700005

The benefits of using selenium in the treatment of Chagas disease:prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice Andréa P de Souza; Linda A Jelicks; Herbert B Tanowitz; Bianca P Olivieri; Monica M Medeiros; Gabriel M Oliveira; Andrea Rodrigues Cordovil Pires; Alessandro M dos Santos; Tania C Araújo-Jorge PAGE: 746-751 | DOI: 10.1590/S0074-02762010000600003

Current status and perspectives of cell therapy in Chagas disease Milena Botelho Pereira Soares; Ricardo Ribeiro dos Santos PAGE: 325-332 | DOI: 10.1590/S0074-02762009000900043

Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors - how to make a dream come true Joseli Lannes-Vieira ; Jaline Coutinho Silverio; Isabela Resende Pereira; Nathália Ferreira Vinagre; Cristiano Marcelo Espinola Carvalho; Cláudia Neto Paiva; Andréa Alice da Silva PAGE: 226-235 | DOI: 10.1590/S0074-02762009000900029

Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research Julio Scharfstein ; Juliana de Assis Silva Gomes; Rodrigo Correa-Oliveira PAGE: 187-198 | DOI: 10.1590/S0074-02762009000900025

Studies of Membrane Fluidity and Heart Contractile Force in Trypanosoma cruzi Infected Mice Julio E Enders, A Ruth Fernández, Héctor W Rivarola, Patricia A Paglini, José A Palma PAGE: 691-696

Severity of chronic experimental Chagas’ heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease Isabela Resende Pereira, Glaucia Vilar-Pereira, Andrea Alice da Silva, Joseli Lannes-Vieira PAGE: 289-298 | DOI: 10.1590/0074-0276140033

Immunopathology of Cardiomyopathy in the Experimental Chagas Disease Milena BP Soares, Ricardo Ribeiro dos Santos PAGE: 257-262

Immunosuppressive Drugs as a Tool to Explore Immunopathology in Experimental Chagas Disease KS Calabrese PAGE: 273-276

Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland Yves Jackson, Drenusha Vieira de Mello Pula, Axel Finckh, Carlo Chizzolini, François Chappuis DOI: 10.1590/0074-02760170383

Single nucleotide polymorphisms of cytokine-related genes and association with clinical outcome in a Chagas disease case-control study from Brazil Lucia Elena Alvarado-Arnez, Angelica Martins Batista, Silvia Marinho Alves, Gloria Melo, Virgínia Maria Barros de Lorena, Cynthia C Cardoso, Isabela Resende Pereira, Cristina Carrazzone, Antonio G Pacheco, Wilson Oliveira Jr, Milton Ozório Moraes, Joseli Lannes-Vieira DOI: 10.1590/0074-02760170489

Curcumin exerts anti-inflammatory and vasoprotective effects through amelioration of NFAT-dependent endothelin-1 production in mice with acute Chagas cardiomyopathy Matías Hernández, Susana Wicz, Miguel H Santamaría, Ricardo S Corral DOI: 10.1590/0074-02760180171

Antiparasitic and anti-inflammatory activities of ß-lapachone-derived naphthoimidazoles in experimental acute Trypanosoma cruzi infection Cynthia M Cascabulho, Marcelo Meuser-Batista, Kelly Cristina G de Moura, Maria do Carmo Pinto, Thabata Lopes Alberto Duque, Kelly C Demarque, Ana Carolina Ramos Guimarães, Pedro Paulo de Abreu Manso, Marcelo Pelajo-Machado, Gabriel M Oliveira, Solange L De Castro, Rubem FS Menna-Barreto DOI: 10.1590/0074-02760190389